Literature DB >> 23926248

Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions.

Johannes Prox1, Christian Bernreuther, Hermann Altmeppen, Jasper Grendel, Markus Glatzel, Rudi D'Hooge, Stijn Stroobants, Tariq Ahmed, Detlef Balschun, Michael Willem, Sven Lammich, Dirk Isbrandt, Michaela Schweizer, Katrien Horré, Bart De Strooper, Paul Saftig.   

Abstract

The metalloproteinase ADAM10 is of importance for Notch-dependent cortical brain development. The protease is tightly linked with α-secretase activity toward the amyloid precursor protein (APP) substrate. Increasing ADAM10 activity is suggested as a therapy to prevent the production of the neurotoxic amyloid β (Aβ) peptide in Alzheimer's disease. To investigate the function of ADAM10 in postnatal brain, we generated Adam10 conditional knock-out (A10cKO) mice using a CaMKIIα-Cre deleter strain. The lack of ADAM10 protein expression was evident in the brain cortex leading to a reduced generation of sAPPα and increased levels of sAPPβ and endogenous Aβ peptides. The A10cKO mice are characterized by weight loss and increased mortality after weaning associated with seizures. Behavioral comparison of adult mice revealed that the loss of ADAM10 in the A10cKO mice resulted in decreased neuromotor abilities and reduced learning performance, which were associated with altered in vivo network activities in the hippocampal CA1 region and impaired synaptic function. Histological and ultrastructural analysis of ADAM10-depleted brain revealed astrogliosis, microglia activation, and impaired number and altered morphology of postsynaptic spine structures. A defect in spine morphology was further supported by a reduction of the expression of NMDA receptors subunit 2A and 2B. The reduced shedding of essential postsynaptic cell adhesion proteins such as N-Cadherin, Nectin-1, and APP may explain the postsynaptic defects and the impaired learning, altered network activity, and synaptic plasticity of the A10cKO mice. Our study reveals that ADAM10 is instrumental for synaptic and neuronal network function in the adult murine brain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23926248      PMCID: PMC6619719          DOI: 10.1523/JNEUROSCI.5910-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  Nuclear Notch1 signaling and the regulation of dendritic development.

Authors:  L Redmond; S R Oh; C Hicks; G Weinmaster; A Ghosh
Journal:  Nat Neurosci       Date:  2000-01       Impact factor: 24.884

Review 2.  Theta oscillations in the hippocampus.

Authors:  György Buzsáki
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

3.  Regulated cleavage of a contact-mediated axon repellent.

Authors:  M Hattori; M Osterfield; J G Flanagan
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

4.  Hippocampal network patterns of activity in the mouse.

Authors:  G Buzsáki; D L Buhl; K D Harris; J Csicsvari; B Czéh; A Morozov
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

6.  ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles.

Authors:  Paul Gutwein; Sabine Mechtersheimer; Svenja Riedle; Alexander Stoeck; Daniela Gast; Safwan Joumaa; Hanswalter Zentgraf; Mina Fogel; D Peter Altevogt
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

7.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein.

Authors:  B Vincent; E Paitel; P Saftig; Y Frobert; D Hartmann; B De Strooper; J Grassi; E Lopez-Perez; F Checler
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

8.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

9.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  Nectin: an adhesion molecule involved in formation of synapses.

Authors:  Akira Mizoguchi; Hiroyuki Nakanishi; Kazushi Kimura; Kaho Matsubara; Kumi Ozaki-Kuroda; Tatsuo Katata; Tomoyuki Honda; Yoshimoto Kiyohara; Kyun Heo; Mikito Higashi; Tomonari Tsutsumi; Satomi Sonoda; Chizuka Ide; Yoshimi Takai
Journal:  J Cell Biol       Date:  2002-02-04       Impact factor: 10.539

View more
  55 in total

1.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

2.  Arc/Arg3.1 mediates a critical period for spatial learning and hippocampal networks.

Authors:  Xiaoyan Gao; Sergio Castro-Gomez; Jasper Grendel; Sabine Graf; Ute Süsens; Lars Binkle; Daniel Mensching; Dirk Isbrandt; Dietmar Kuhl; Ora Ohana
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-15       Impact factor: 11.205

Review 3.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

4.  Shedding the epilepsy comorbidity in Alzheimer's disease.

Authors:  Elizabeth M Powell
Journal:  Epilepsy Curr       Date:  2014-07       Impact factor: 7.500

5.  Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in Arc/Arg3.1 Deficient Mice.

Authors:  Xiaoyan Gao; Jasper Grendel; Mary Muhia; Sergio Castro-Gomez; Ute Süsens; Dirk Isbrandt; Matthias Kneussel; Dietmar Kuhl; Ora Ohana
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

6.  Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release.

Authors:  Emilia Servián-Morilla; Estefanía Robles-Lanuza; Ana C Sánchez-Hidalgo; Rafael J Camacho-Garcia; Juan A Paez-Gomez; Fabiola Mavillard; Carlos A Saura; Amalia Martinez-Mir; Francisco G Scholl
Journal:  J Neurosci       Date:  2017-12-11       Impact factor: 6.167

7.  The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Authors:  Tobias Brummer; Martina Pigoni; Armando Rossello; Huanhuan Wang; Peter J Noy; Michael G Tomlinson; Carl P Blobel; Stefan F Lichtenthaler
Journal:  FASEB J       Date:  2018-02-07       Impact factor: 5.191

Review 8.  Not just amyloid: physiological functions of the amyloid precursor protein family.

Authors:  Ulrike C Müller; Thomas Deller; Martin Korte
Journal:  Nat Rev Neurosci       Date:  2017-03-31       Impact factor: 34.870

9.  In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15.

Authors:  Lisa Seipold; Hermann Altmeppen; Tomas Koudelka; Andreas Tholey; Petr Kasparek; Radislav Sedlacek; Michaela Schweizer; Julia Bär; Marina Mikhaylova; Markus Glatzel; Paul Saftig
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

10.  Non-cell-autonomous function of DR6 in Schwann cell proliferation.

Authors:  Alessio Colombo; Hung-En Hsia; Mengzhe Wang; Peer-Hendrik Kuhn; Monika S Brill; Paolo Canevazzi; Regina Feederle; Carla Taveggia; Thomas Misgeld; Stefan F Lichtenthaler
Journal:  EMBO J       Date:  2018-02-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.